Английская Википедия:5-Methoxy-7,N,N-trimethyltryptamine

Материал из Онлайн справочника
Версия от 06:54, 26 декабря 2023; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Chemical compound}} {{DISPLAYTITLE:5-Methoxy-7,''N'',''N''-trimethyltryptamine}} {{Drugbox | Verifiedfields = changed | verifiedrevid = 477225204 | IUPAC_name = 2-(5-Methoxy-7-methyl-1''H''-indol-3-yl)-''N'',''N''-dimethylethanamine | image = 5-MeO-7-TMT.png | drug_name = 5-Methoxy-7,''N'',''N''-trimethyltryptamine <!--Clinical data--> | tradename = <!--Identifiers-...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description

Шаблон:Drugbox

5-Methoxy-7,N,N-trimethyltryptamine (5-MeO-7,N,N-TMT, 5-MeO-7-TMT), is a tryptamine derivative which acts as a partial agonist at the 5-HT2 serotonin receptors, with an EC50 of 63.9 nM and an efficacy of 66.2% at 5-HT2A (vs 5-HT), and weaker activity at 5-HT2B and 5-HT2C.[1][2][3] In animal tests, both 7,N,N-TMT and 5-MeO-7,N,N-TMT produced behavioural responses similar to those of psychedelic drugs such as DMT and 5-MeO-DMT, but compounds with larger 7-position substituents such as 7-ethyl-DMT and 7-bromo-DMT did not produce psychedelic-appropriate responding despite high 5-HT2 receptor binding affinity, suggesting these may be antagonists or weak partial agonists for the 5-HT2 receptors.[4] The related compound 7-MeO-MiPT (cf. 5-MeO-MiPT) was also found to be inactive, suggesting that the 7-position has poor tolerance for bulky groups at this position, at least if agonist activity is desired.[5]

See also

References

Шаблон:Reflist

Шаблон:Serotonergics Шаблон:Tryptamines


Шаблон:Nervous-system-drug-stub